Association of Donor Characteristics and Graft Storage Time with Survivorship of Osteochondral Allograft Transplantation in the Knee
Orthopaedic journal of sports medicine · 2026
Donor age >20y and early graft release (<14 days) were linked to roughly 7x higher OCA failure risk over 8 years; donor BMI and sex-matching made no difference.
The paper
Retrospective cohort, n=220 patients (236 knees) undergoing primary fresh osteochondral allograft (OCA) transplantation of the knee for focal, non-degenerative chondral/osteochondral lesions, mean follow-up 8.2 years.
What they found
Grafts from donors >20 years old failed more often than grafts from younger donors (11.7% vs 3.7%, P=.039; 10-year survival 89.3% vs 100%), and grafts released early (1-14 days) failed more often than those released late (15-28 days) (22.7% vs 6%, P=.002; 10-year survivorship 85.6% vs 96.1%). Older donor age and early release were each linked to roughly a 7-fold higher failure risk; donor BMI, sex-matching, and IKDC/satisfaction scores showed no significant differences.
The appraisal
This is a Level 3 retrospective cohort from a single high-volume allograft program, comparing subgroups defined post hoc by donor characteristics rather than a pre-specified randomised design, so confounding by lesion size, location, recipient factors and concomitant procedures cannot be excluded. The donor age split (≤20 vs >20 years) is also a fairly blunt tool: most fresh OCA programmes accept donors well into their 30s or 40s, so the '>20' group likely spans two decades or more, meaning this cut can't tell us whether failure risk climbs gradually with age or jumps at some later threshold. Four separate donor/storage comparisons were tested with no stated correction for multiple comparisons, and the P values (.039.002) sit close to conventional thresholds while failure counts in some subgroups look small, meaning the true precision around that 'roughly 7-fold' risk is probably wider than the point estimate suggests since no confidence intervals are reported. Long mean follow-up (8.2 years) is a genuine strength, but this is hypothesis-generating association data, not proof that donor age or storage window causes failure.
The gap
No adjustment for recipient- or surgery-level confounders (lesion size/location, concomitant procedures, recipient age) and no confidence intervals around the failure-risk estimates, so it's unclear how much of this is signal versus noise; a multivariable model or an independent replication cohort would be needed before treating donor age or storage window as causal.
Landmark context
This adds to a small but growing literature on donor-side factors in fresh OCA transplantation, an area that has had far less scrutiny than recipient-side variables like lesion size or concomitant procedures. It also pushes back against the simple assumption behind extended-storage systems such as the Missouri Osteochondral Allograft Preservation System, that fresher grafts should outperform older-stored ones on chondrocyte viability grounds: here, earlier-released grafts actually failed more often, not less. Whether that reflects true storage biology, an unmeasured difference in which grafts get released early (e.g. tissue bank or donor screening practices), or chance in a modest sample isn't resolved by this study alone.
What to do Monday
This doesn't change bedside physio or S&C management, it's a graft-selection and informed-consent factor for the orthopaedic surgeon and tissue bank. When counselling a patient going for OCA, failure risk discussions may reasonably factor in donor age, and clinicians shouldn't assume a 'fresher graft' is automatically the safer choice.
In practice
This is squarely a pre-op, consent-stage decision for the surgeon and tissue bank, so it doesn't change the post-op OCA rehab protocol I'd run with any patient, protected weight-bearing progression and a staged return to impact around 9-12 months stays the same regardless of donor age or storage time. Where it's useful clinic-side: if a patient mentions their surgeon flagged an older-donor or early-released graft, treat that as a cue to be a bit more vigilant through late-stage rehab, watching closely for effusion, mechanical symptoms or an IKDC plateau rather than assuming time-based milestones guarantee success. Same logic applies on the S&C floor for return-to-sport programming, don't blanket-clear every post-OCA athlete on the same timeline; where higher failure risk is known, bias toward a longer, more graded reintroduction of cutting and plyometric volume with closer monitoring. Caveat: this donor information usually isn't shared with the treating physio or coach in real-world practice, and it's retrospective association data, not causal, so it should sharpen vigilance rather than justify holding back an otherwise well-progressing patient.
The five papers that matter — every week, free.
We read the whole sports-medicine, rehab & performance literature and appraise the papers worth your time.
Get the free weekly issueRelated appraisals
Read in your language: English · Français · Deutsch · Español · Italiano · Nederlands · Dansk · Svenska